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Similarly anti nitric oxide agents failed in a long term study to slow
down the progression of knee OA.
Owing to these repeated negative results with biologics, new strategies
should be contemplated such as gene therapy.
On the other hand, new emerging treatments may be more related on
the repair side of cartilage. This could be targeted by using growth factor
delivery. Intra articular administration of autologous platelets is widely
used by the level of proofs still need to be conﬁrmed in large
randomized trials. One placebo controlled study using repeated intra
articular administration of FGF 18 failed to demonstrate neither any
pain relief nor any structural changes. The therapeutically option con-
sisting in the intra articular administration of autologous stem cells is
ongoing in a phase 1 study in humans. In the next future, new lubricants
agents such recombinant lubricin also offers an appealing approach.
Finally, recent placebo controlled study with ranelate strontium,
a decoupling bone agent, showed promising results on the evolution of
joint space narrowing in patients with knee OA.
Conclusions: Looking for new treatments options in OA should not only
consider new drugs with an appealing mechanism of action but should
also consider to whom patient and when those therapies could be at
best prescribed.
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A STEM CELL-BASED APPROACH TO CARTILAGE REPAIR
K.A. Johnson. Genomics Inst. of the Novartis Res. Fndn., San Diego, CA, USA
Osteoarthritis (OA) is a degenerative joint disease that involves
destruction of articular cartilage and eventually leads to disability.
Molecules that promote the selective differentiation of multi-potent
mesenchymal stem cells (MSCs) in to chondrocytes may stimulate the
repair of damaged cartilage. Using an image-based, high throughput
screen we identiﬁed the small molecule kartogenin, which promotes
selective chondrocytes differentiation (EC50 ¼ 100 nM), shows chon-
dro-protective effects in vitro, and is efﬁcacious in two OA animal
models. Kartogenin binds ﬁlamin A (FLNA), disrupts its interaction with
the transcription factor CBFb and induces chondrogenesis by regulating
the CBFb-RUNX1 transcriptional program. This work provides new
insight into the control of chondrogenesis that may ultimately lead to
a stem-cell based therapy for osteoarthritis.
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SURGICAL ASPECTS OF OA (MENISCUS)
M. Englund y,z. y Lund Univ., Lund, Sweden; zBoston Univ. Sch. of Med.,
Boston, MA, USA
The menisci are internal structures that are of central importance for
a healthy knee joint; they have a key role in the structural progression
of knee osteoarthritis (OA), and the risk of the disease dramatically
increases if they are damaged by injury or degenerative processes.
Meniscus damage might be considered a signifying feature of incipient
OA in middle-aged and elderly people. As approximately every third
knee of people in this group has a damaged meniscus, tears are
common incidental ﬁndings of knee MRI. However, as most tears do not
cause symptoms, careful clinical evaluation is required to determine if
a damaged meniscus is likely to directly impact a patient's symptoms.
Conservative management of patients with knee pain and a degenera-
tive meniscal tear should be considered as a ﬁrst-line therapy before
surgical treatment is contemplated. Patients with mechanical interfer-
ence of joint movements, such as painful catching or locking, might
need surgical treatment with meniscal repair if possible. In a subset of
patients, meniscal resection might relieve pain and other symptoms
that potentially originate directly from the torn meniscus. However, the
possibility of an increased risk of OA if functional meniscal tissue is
removed cannot be overlooked.
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AUTOPHAGY IN THE PATHOGENESIS OF AGING-RELATED OA
B. Caramés. Osteoarticular and Aging Res. Lab., INIBIC – Inst. of BioMed.
Res. of A Coruña, A Coruña, Spain
Although aging represents one of the most important risk factor for OA,
mechanisms leading to aging-related cartilage degeneration remain to
be determined. Consequently, there are no approaches to target aging-related changes in cartilage therapeutically, even in preclinical experi-
mental models. Autophagy plays a fundamental role in cellular
homeostasis and organismal health. It is a major physiological mecha-
nism that eliminates altered and dysfunctional cytosolic macromole-
cules, membranes and organelles by lysosomal degradation. In most
experimental models, suppression of relevant autophagy genes leads to
cell death, indicating a protective and survival-promoting function. In
articular cartilage, which is characterized by a very low rate of cell
turnover this mechanism appears to be essential to maintain cellular
integrity, function and survival. Furthermore, while aging-related
changes in autophagy have been demonstrated in various models and
tissues, this is only the beginning of studies focus on articular cartilage.
Our recent observations in human knee joints and in experimental
models indicate that aging and OA are associated with defective auto-
phagy in articular cartilage. This provides a unique opportunity to study
a new dimension of cartilage aging mechanisms and simultaneously
explore the therapeutic potential of pharmacological enhancement of
autophagy in OA.
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OPTIMAL COMBINATIONS OF SCAFFOLDS AND GROWTH FACTORS
FOR TISSUE ENGINEERING OF CARTILAGE
K. Hoshi. The Univ. of Tokyo, Tokyo, Japan
Purpose: Since cartilage has poor regenerative capacity by itself, its
regeneration using a tissue engineering technique may greatly beneﬁt
the treatment of various cartilage disorders that cannot be treated by
conventional methods. Although autologous chondrocyte trans-
plantation has been already available for clinical use, the size is limited
to a ﬁller of focal articular cartilage defect or an injectable material for
the nasal cosmetic augmentation. In order to broaden its clinical indi-
cation to major disorders such as osteoarthritic joints, microtia or cleft
lip/palate, we should make an “implant-type” tissue-engineered carti-
lage with a greater ﬁrmness and a 3D-structure.
Methods: For that, we developed 1) a proliferation medium for
chondrocytes to realize a more than 1000-fold increase in number
without using fetal bovine serum that has been restricted to clinical
application, and 2) a scaffold system that effectively preserves chon-
drocytes in the engineered tissue and provides the adequate 3D shape
to the tissue.
Results: For the proliferation medium, we examined the optimal
combination from 12 putative soluble chondrocyte regulators including
FGF-2, IGF-I, insulin, BMP-2, PTH and others. Using the statistical
method that is termed “analysis of variance by fractional factorial
design”, the effects of the individual factors and the synergy of the
combinations were evaluated. As a result, the combination of FGF-2 and
insulin with 5% human serum showed a 10–12-fold increase in number
within one week and provided an approximate 1000-fold increase
around 3 weeks. In order to fabricate the scaffold system, we should
realize 1) sufﬁcient mechanical strength mimicking native cartilage, 2)
preservation of seeded cells and their even distribution, and 3) good
biocompatibility/biodegradability. To meet with these requirements,
we decided to use the combination of hydrogel and porous scaffolds.
Considering biological effects and clinical availability, atelocollagenmay
be accessible for hydrogel. Next, we investigated the structure and
composition of porous scaffolds. We prepared ones of a classical poly-
mer PLLA or PLGA with various kinds of porosity and pore sizes. The
porous scaffolds possessed sufﬁcient strength even with high porosity
(>95%) and good interconnectivity, which showed favorable cartilage
regeneration when transplanted in the subcutaneous space of nude
mice with chondrocyte/atelocollagen mixture. In order to examine the
biocompatibility, we conducted a canine model for autologous trans-
plantation of the tissue-engineered cartilage, and compared between
such scaffolds of PLLA and PLGA. The tissue-engineered constructs
using PLLA contained abundant cartilage after transplantation,
although the PLGA constructs did not show the cartilage and could not
maintain their shapes. The PLLA scaffolds were suitable for cartilage
tissue engineering under the immunocompetent conditions, because of
the retard at degradation properties and the decrease in the severe
tissue reactions during the early stage of transplantation.
Conclusions: With these technologies, we applied the implant-type
tissue-engineered cartilage for treatment of a nasal deformity in
patients with cleft lip/palate. We would also apply these elemental
techniques for the development of tissue-engineered trachea or joints,
and the preclinical experiments are underway. We hope these tissue-
